• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症运动起始年龄受TCERG1中串联六聚体重复序列的影响。

Huntington's disease age at motor onset is modified by the tandem hexamer repeat in TCERG1.

作者信息

Lobanov Sergey V, McAllister Branduff, McDade-Kumar Mia, Landwehrmeyer G Bernhard, Orth Michael, Rosser Anne E, Paulsen Jane S, Lee Jong-Min, MacDonald Marcy E, Gusella James F, Long Jeffrey D, Ryten Mina, Williams Nigel M, Holmans Peter, Massey Thomas H, Jones Lesley

机构信息

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.

Department of Neurology, University of Ulm, Ulm, Germany.

出版信息

NPJ Genom Med. 2022 Sep 5;7(1):53. doi: 10.1038/s41525-022-00317-w.

DOI:10.1038/s41525-022-00317-w
PMID:36064847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9445028/
Abstract

Huntington's disease is caused by an expanded CAG tract in HTT. The length of the CAG tract accounts for over half the variance in age at onset of disease, and is influenced by other genetic factors, mostly implicating the DNA maintenance machinery. We examined a single nucleotide variant, rs79727797, on chromosome 5 in the TCERG1 gene, previously reported to be associated with Huntington's disease and a quasi-tandem repeat (QTR) hexamer in exon 4 of TCERG1 with a central pure repeat. We developed a method for calling perfect and imperfect repeats from exome-sequencing data, and tested association between the QTR in TCERG1 and residual age at motor onset (after correcting for the effects of CAG length in the HTT gene) in 610 individuals with Huntington's disease via regression analysis. We found a significant association between age at onset and the sum of the repeat lengths from both alleles of the QTR (p = 2.1 × 10), with each added repeat hexamer reducing age at onset by one year (95% confidence interval [0.7, 1.4]). This association explained that previously observed with rs79727797. The association with age at onset in the genome-wide association study is due to a QTR hexamer in TCERG1, translated to a glutamine/alanine tract in the protein. We could not distinguish whether this was due to cis-effects of the hexamer repeat on gene expression or of the encoded glutamine/alanine tract in the protein. These results motivate further study of the mechanisms by which TCERG1 modifies onset of HD.

摘要

亨廷顿舞蹈症由HTT基因中CAG序列的扩增引起。CAG序列的长度占疾病发病年龄方差的一半以上,并受其他遗传因素影响,这些因素大多与DNA维持机制有关。我们研究了位于5号染色体上TCERG1基因的一个单核苷酸变体rs79727797,该变体先前被报道与亨廷顿舞蹈症相关,同时还研究了TCERG1基因第4外显子中的一个准串联重复(QTR)六聚体,其具有一个中心纯重复序列。我们开发了一种从外显子组测序数据中识别完美和不完美重复序列的方法,并通过回归分析测试了610名亨廷顿舞蹈症患者中TCERG1基因的QTR与运动发病剩余年龄(校正HTT基因中CAG长度的影响后)之间的关联。我们发现发病年龄与QTR两个等位基因重复序列长度之和之间存在显著关联(p = 2.1×10),每增加一个重复六聚体,发病年龄就降低一岁(95%置信区间[0.7, 1.4])。这种关联解释了先前观察到的与rs79727797的关联。全基因组关联研究中与发病年龄的关联是由于TCERG1基因中的一个QTR六聚体,该六聚体在蛋白质中翻译为谷氨酰胺/丙氨酸序列。我们无法区分这是由于六聚体重复序列对基因表达的顺式效应,还是由于蛋白质中编码的谷氨酰胺/丙氨酸序列的顺式效应。这些结果促使人们进一步研究TCERG1修饰亨廷顿舞蹈症发病的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f35/9445028/7d4ab1ab088c/41525_2022_317_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f35/9445028/54ccc1e796b6/41525_2022_317_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f35/9445028/ad21f2e6c0ae/41525_2022_317_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f35/9445028/922604f28788/41525_2022_317_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f35/9445028/7d4ab1ab088c/41525_2022_317_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f35/9445028/54ccc1e796b6/41525_2022_317_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f35/9445028/ad21f2e6c0ae/41525_2022_317_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f35/9445028/922604f28788/41525_2022_317_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f35/9445028/7d4ab1ab088c/41525_2022_317_Fig4_HTML.jpg

相似文献

1
Huntington's disease age at motor onset is modified by the tandem hexamer repeat in TCERG1.亨廷顿舞蹈症运动起始年龄受TCERG1中串联六聚体重复序列的影响。
NPJ Genom Med. 2022 Sep 5;7(1):53. doi: 10.1038/s41525-022-00317-w.
2
Modification of Huntington's disease by short tandem repeats.短串联重复序列对亨廷顿舞蹈症的修饰作用
Brain Commun. 2024 Jan 23;6(2):fcae016. doi: 10.1093/braincomms/fcae016. eCollection 2024.
3
Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.亨廷顿病中断序列变异和发病年龄:临床意义和新兴疗法。
Lancet Neurol. 2020 Nov;19(11):930-939. doi: 10.1016/S1474-4422(20)30343-4.
4
Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.针对委内瑞拉大型家系中亨廷顿舞蹈病发病剩余年龄的十二项关联研究的重复验证。
J Med Genet. 2007 Jan;44(1):44-50. doi: 10.1136/jmg.2006.045153. Epub 2006 Oct 3.
5
Investigation of the Influence of TBP CAG/CAA Repeats in Conjunction with HTT CAG Repeats on Huntington's Disease Age at Onset in a Brazilian Sample.探讨 TBP CAG/CAA 重复与 HTT CAG 重复联合对巴西人群亨廷顿病发病年龄的影响。
J Mol Neurosci. 2022 May;72(5):1116-1124. doi: 10.1007/s12031-021-01938-z. Epub 2022 Mar 11.
6
FAN1 modifies Huntington's disease progression by stabilizing the expanded HTT CAG repeat.FAN1 通过稳定扩展的 HTT CAG 重复序列来修饰亨廷顿病的进展。
Hum Mol Genet. 2019 Feb 15;28(4):650-661. doi: 10.1093/hmg/ddy375.
7
Loss of CAA interruption and intergenerational CAG instability in Chinese patients with Huntington's disease.中国亨廷顿病患者 CAA 中断缺失和跨代 CAG 不稳定性。
J Mol Med (Berl). 2023 Jul;101(7):869-876. doi: 10.1007/s00109-023-02329-0. Epub 2023 May 26.
8
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.鉴定与亨廷顿病进展相关的遗传变异:全基因组关联研究。
Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20.
9
Association Analysis of Chromosome X to Identify Genetic Modifiers of Huntington's Disease.X 染色体关联分析鉴定亨廷顿病的遗传修饰因子。
J Huntingtons Dis. 2021;10(3):367-375. doi: 10.3233/JHD-210485.
10
CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset.CAG 重复序列而非多聚谷氨酰胺长度决定亨廷顿病发病时间。
Cell. 2019 Aug 8;178(4):887-900.e14. doi: 10.1016/j.cell.2019.06.036.

引用本文的文献

1
Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease highlight shared and tissue-specific effects.亨廷顿舞蹈病中体细胞扩增和临床表型的遗传修饰因子凸显了共同效应和组织特异性效应。
Nat Genet. 2025 Jun;57(6):1426-1436. doi: 10.1038/s41588-025-02191-5. Epub 2025 Jun 9.
2
Multi-epitope immunocapture of huntingtin reveals striatum-selective molecular signatures.亨廷顿蛋白的多表位免疫捕获揭示了纹状体选择性分子特征。
Mol Syst Biol. 2025 May;21(5):492-522. doi: 10.1038/s44320-025-00096-3. Epub 2025 Apr 1.
3
Huntingtin interactome reveals huntingtin role in regulation of double strand break DNA damage response (DSB/DDR), chromatin remodeling and RNA processing pathways.

本文引用的文献

1
Exome sequencing of individuals with Huntington's disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset.亨廷顿病患者外显子组测序提示 FAN1 核酸酶活性可减缓 CAG 扩展和疾病发病。
Nat Neurosci. 2022 Apr;25(4):446-457. doi: 10.1038/s41593-022-01033-5. Epub 2022 Apr 4.
2
Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.亨廷顿舞蹈症患者精神、认知及运动异常的发生时间与影响
Neurology. 2021 May 11;96(19):e2395-e2406. doi: 10.1212/WNL.0000000000011893. Epub 2021 Mar 25.
3
Shape deformation analysis reveals the temporal dynamics of cell-type-specific homeostatic and pathogenic responses to mutant huntingtin.
亨廷顿相互作用组揭示了亨廷顿蛋白在双链断裂DNA损伤反应(DSB/DDR)、染色质重塑和RNA加工途径调控中的作用。
bioRxiv. 2024 Dec 27:2024.12.27.630542. doi: 10.1101/2024.12.27.630542.
4
Atypical Presentations of Huntington Disease-like 2 in South African Individuals.亨廷顿病样 2 在南非个体中的非典型表现。
Mov Disord Clin Pract. 2024 Jul;11(7):850-854. doi: 10.1002/mdc3.14052. Epub 2024 May 9.
5
Modification of Huntington's disease by short tandem repeats.短串联重复序列对亨廷顿舞蹈症的修饰作用
Brain Commun. 2024 Jan 23;6(2):fcae016. doi: 10.1093/braincomms/fcae016. eCollection 2024.
6
From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington's Disease Research.从发病机制到治疗:亨廷顿病研究 150 年回顾。
Int J Mol Sci. 2023 Aug 21;24(16):13021. doi: 10.3390/ijms241613021.
形态变形分析揭示了突变亨廷顿蛋白导致的细胞类型特异性内在平衡和致病反应的时间动态。
Elife. 2021 Feb 23;10:e64984. doi: 10.7554/eLife.64984.
4
The mutational constraint spectrum quantified from variation in 141,456 humans.从 141456 名人类个体的变异中量化的突变约束谱。
Nature. 2020 May;581(7809):434-443. doi: 10.1038/s41586-020-2308-7. Epub 2020 May 27.
5
On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability.在错误的 DNA 轨道上:重复介导的基因组不稳定性的分子机制。
J Biol Chem. 2020 Mar 27;295(13):4134-4170. doi: 10.1074/jbc.REV119.007678. Epub 2020 Feb 14.
6
Role for the splicing factor TCERG1 in Cajal body integrity and snRNP assembly.剪接因子 TCERG1 在 Cajal 体完整性和 snRNP 组装中的作用。
J Cell Sci. 2019 Nov 14;132(22):jcs232728. doi: 10.1242/jcs.232728.
7
cis Elements that Mediate RNA Polymerase II Pausing Regulate Human Gene Expression.顺式作用元件调控 RNA 聚合酶 II 暂停调节人类基因表达。
Am J Hum Genet. 2019 Oct 3;105(4):677-688. doi: 10.1016/j.ajhg.2019.08.003. Epub 2019 Sep 5.
8
CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset.CAG 重复序列而非多聚谷氨酰胺长度决定亨廷顿病发病时间。
Cell. 2019 Aug 8;178(4):887-900.e14. doi: 10.1016/j.cell.2019.06.036.
9
DNA Damage Repair in Huntington's Disease and Other Neurodegenerative Diseases.亨廷顿病和其他神经退行性疾病中的 DNA 损伤修复。
Neurotherapeutics. 2019 Oct;16(4):948-956. doi: 10.1007/s13311-019-00768-7.
10
Profiling the genome-wide landscape of tandem repeat expansions.全基因组串联重复扩展图谱分析。
Nucleic Acids Res. 2019 Sep 5;47(15):e90. doi: 10.1093/nar/gkz501.